Clinical trial Recruiting at 1 site Observational Ages 45 to 90

Online cognitive testing for people with Parkinson's disease

Official title: Deep Cognitive Endophenotyping of Parkinson's Disease: A Platform Development and Pilot Study

Run by McGill University · NCT05025254 · Data updated 2026-11-12

This study is testing if online cognitive tests can be reliable and helpful for people with Parkinson's disease.

Quick facts

Study typeObservational
Ages45 Years to 90 Years
SexAll
Enrollment1000 (estimated)
SponsorMcGill University
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedAugust 2021
Main results expectedSeptember 2022
Study endsDecember 2026
Registry record updatedAugust 27, 2021
Trial IDNCT05025254 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with Parkinson's disease or healthy individuals without any neurological illnesses.

Probably not a fit

Patients with psychotic disorders, advanced dementia, or other significant neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study aims to assess the feasibility and reliability of conducting large-scale online neurocognitive testing specifically for individuals with Parkinson's disease. It will involve both in-lab and online testing to validate the effectiveness of these cognitive assessments. The study seeks to establish a protocol for future research in this area, which has not been extensively explored in Parkinson's research despite its growing use in psychiatry.

Why it matters

Potential benefit: If successful, this study could lead to more accessible and effective cognitive assessments for patients with Parkinson's disease.

How similar studies have gone: While large-scale online cognitive testing has been successful in psychiatry, this approach in Parkinson's research is novel and untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of Parkinson's disease by neurologist or healthy individual with no diagnosis of any neurological illness

Exclusion Criteria:

* Psychotic spectrum disorders, active uncontrolled depression, advanced dementia (i.e. needing assistance with daily activities such as dressing or bathing), major stroke, major head injury, epilepsy requiring anti-seizure medications

Where it's running

  • McGill University Health Centre
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.